Studies on no-specifical immunoregulatory effects to the host by the addministration of newly activated-peptides derived from Toxoplasma lysate substance

弓形虫裂解物衍生的新激活肽对宿主的非特异性免疫调节作用的研究

基本信息

项目摘要

An imunomodulator, such as TLA (Toxoplasma lysate antigens) was tested in the experiments. Growth of the tumor autoinduced by 20-methylcholanthrene (MC) in rats and mice was inhibited after intramuscular injection of TLA.The antitumor activity of TLA was most obvious in the early stage of tumor growth. When TLA was administered to rats before the appearance of tumor, tumor formation was delayd slightly. According to the immunohistological examination of tumor tisue with anti-Thy-1 antibody, the rats treated with TLA showed large Thy-1 positive or Lymphokine-Activated Killer (LAK) cells, whereas the untreated rats indicated only a few small Thy-1 positive or NK cells. In a series of these studies, TLA induces NK cells, cytotoxic T-lymphocytes and LAK cells in animals after injection, and the induction of these killer cells needs to exist in combination with macrophages and lymphocytes in in vivo. An activity unit in TLA was isolated now as TLA-H6E,and the inhibitory activation to the tu … More mor growth was significantly strong in comparison with others. Using the TLA-H6E monoclonal antibody, the structure of H6E is now making clear.Newly synthesized peptides of the activity units which were isolated from cytokines (lymphokines) as an immunoregulator, Obiopeptide, were examined in the effect of Toxoplasma chronically infected animals. Mice chronically infected with Toxoplasma were treated with Chclophosphamide (Cyp), Obiopeptide-1 (Obio-1) and/or anti-CD4 monoclonal antibody to determine the effect of these immunosuppressive agents on the cysts in the brain. In the brain of non-treated, and infected Cyp-Obi-1 treated mice, with HE staining or anti-Toxoplasma ABC labelling staining, large typically rounded tissue cysts were mostly detected, and in some regions dividing microcysts were also founded. In contrast, brain tissue from Cyp only or anti-CD4 treated infected mice had multiple degenerated cysts of varied sizes in some brain regions, as well as clusters of microcysts, however, such change was more striking in the anti-CD4 treated mice. Infected mice treated with a combination of Cyp and Obi-1 showed a significantly higher survival of 80% compared to 20% survival in mice treated with Cyp only. Percent neutrophilic leucocytes, monocytes and lymphocytes in mice treated with a combination of Obi-1 and anti-CD4, or Obi-1 and Cyp were higher compared to those groups treated with anti-CD4 antibody, or Cyp only. The increase in neutrophilic leucocyte and lymphocyte counts after a combined Cyp and Obi-1 treatment may, like wise, contribute to the induction of resistance in mice aginst Toxoplasma gondii. These results indidcate that reactivation of rupture of tissue cysts in mice treated with Cyp, chronicaly infected with Toxoplasma, might be mainly mediated by CD4 positive cells rather than other CD8, CD5 cells. Furthermore, the increase of neutrophilic leukocytes might contribute to the induction of the resistnce to Toxoplamsa in mice, after treatment with Obi-1 and Cyp in combination. However, these results seem to suggest that the reactivation or rupture of tissue cysts in mice chronically infected with Toxoplasma is not principally correlated with the death of Cyp treated mice. Less
在实验中测试了免疫调节剂,例如TLA(弓形虫裂解物抗原)。TLA肌肉注射对20-甲基胆蒽(MC)诱发的大、小鼠肿瘤生长均有抑制作用,其抑瘤作用在肿瘤生长早期最为明显。在肿瘤形成前给予TLA,肿瘤形成时间稍有延迟。用抗Thy-1抗体对肿瘤组织进行免疫组织化学检查,结果显示TLA治疗组有大量Thy-1阳性细胞或LAK细胞,而未治疗组仅有少量Thy-1阳性细胞或NK细胞。在一系列的这些研究中,TLA在注射后诱导动物体内的NK细胞、细胞毒性T淋巴细胞和LAK细胞,而这些杀伤细胞的诱导需要在体内与巨噬细胞和淋巴细胞联合存在。目前已分离出TLA中的一个活性单位TLA-H6 E, ...更多信息 莫尔生长与其他相比显著强劲。利用TLA-H6 E单克隆抗体,阐明了H6 E的结构,并从细胞因子(淋巴因子)中分离出活性单位的新合成肽,作为免疫调节剂Obiopeptide,对弓形虫慢性感染动物的作用进行了研究。用环磷酰胺(Cyp)、Obio-1和/或抗CD_4单克隆抗体治疗弓形虫慢性感染小鼠,观察这些免疫抑制剂对弓形虫脑内包囊的影响。在未治疗和感染Cyp-Obi-1治疗的小鼠的脑中,用HE染色或抗弓形虫ABC标记染色,大多数检测到大的典型圆形组织囊肿,并且在一些区域中还发现分裂的微囊。相比之下,来自仅Cyp或抗CD 4治疗的感染小鼠的脑组织在某些脑区域中具有多个不同大小的变性囊肿,以及微囊肿簇,然而,这种变化在抗CD 4治疗的小鼠中更显著。用Cyp和Obi-1组合治疗的感染小鼠显示出80%的显著更高的存活率,而仅用Cyp治疗的小鼠的存活率为20%。与用抗CD 4抗体或仅用Cyp处理的那些组相比,用Obi-1和抗CD 4或Obi-1和Cyp的组合处理的小鼠中的嗜中性白细胞、单核细胞和淋巴细胞的百分比更高。Cyp和Obi-1联合治疗后,嗜中性白细胞和淋巴细胞计数的增加可能有助于诱导小鼠对弓形虫的抗性。结果提示,Cyp处理的弓形虫慢性感染小鼠组织包囊破裂后的再激活可能主要是由CD_4 ~+细胞介导的,而不是由其他CD_8、CD_5细胞介导的。Obi-1和Cyp联合治疗后,小鼠体内嗜中性白细胞的增加可能与诱导抗弓形虫有关。然而,这些结果似乎表明,在慢性感染弓形虫的小鼠中,组织包囊的再活化或破裂与Cyp处理的小鼠的死亡没有主要相关性。少

项目成果

期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Saito,A.et al.: "Effects of reactive oxyen intermediate scavengers on antitoxoplasmic activity of activated macrophages" Parasitoogy Research. 78. 28-31 (1992)
Saito,A.et al.:“活性氧中间体清除剂对活化巨噬细胞抗弓形虫活性的影响”寄生虫学研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takahashi,M.,et.al: "Protective immune response of Isospord felisinfected mice against Babesiamicroti infection" Journal of Vet.Medical Science. 55. 587-590 (1993)
Takahashi,M.,et.al:“猫等孢子感染小鼠对巴贝虫感染的保护性免疫反应”兽医医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyahara, K., Mastumoto, T., Tose, S., Sakurai, H., Igarashi, I., Saito, A., Hirose, T.& Suzuki, N.: "Characteristics of cytotoxic cells induced by Toxoplasma lysate antigen (TLA) in mouse spleen" J.Vet.Med.Sci.54. 87-93 (1992)
宫原 K.、松本 T.、东濑 S.、樱井 H.、五十岚 I.、斋藤 A.、广濑 T.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Omata, Y., Oikawa, H., Kanda, M., Mikazuki, K., DiLorenzo, C., Claveria, F.G., Takahashi, M., Igarashi, I., Saito, A.& Suzuki, N.: "Transfer of antibodies to kittens from mother cats chronically infected with Toxoplasma gondii" Veterinary Parasitology. 52
Omata, Y.、Oikawa, H.、Kanda, M.、Mikazuki, K.、DiLorenzo, C.、Claveria, F.G.、Takahashi, M.、Igarashi, I.、Saito, A.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUZUKI Naoyoshi其他文献

SUZUKI Naoyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUZUKI Naoyoshi', 18)}}的其他基金

Developing a Learning Support System for Remote Body Movement Instruction : An Application in Physical Assessment Skill Training
开发远程身体运动指导学习支持系统:在体能评估技能训练中的应用
  • 批准号:
    20300270
  • 财政年份:
    2008
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on newly synthesized peptide as an immunoregulator against protozoan infection
新合成肽作为抗原虫感染免疫调节剂的研究
  • 批准号:
    06556053
  • 财政年份:
    1994
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular Immunological Studies on The Prevention and Diagnoses of Protozoan Infection
原虫感染预防和诊断的分子免疫学研究
  • 批准号:
    03556041
  • 财政年份:
    1991
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Immunopotentiatroy Effects of TLA and Obioactin on the Acquired Immunodeficiency Syndroms (AIDS) in animals
TLA 和 Obioactin 对动物获得性免疫缺陷综合症 (AIDS) 的免疫增强作用
  • 批准号:
    62440020
  • 财政年份:
    1987
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Studies on the non-specific immunomodulator effects in animals by treatment of Toxoplasma lysate antigens
弓形虫裂解物抗原治疗动物非特异性免疫调节作用的研究
  • 批准号:
    59440017
  • 财政年份:
    1984
  • 资助金额:
    $ 18.05万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)

相似海外基金

The Leadership Alliance Innovative Programs to Enhance Research Training (TLA-IPERT)
领导力联盟创新计划加强研究培训 (TLA-IPERT)
  • 批准号:
    9308991
  • 财政年份:
    2015
  • 资助金额:
    $ 18.05万
  • 项目类别:
The Leadership Alliance Innovative Programs to Enhance Research Training (TLA-IPERT)
领导力联盟创新计划加强研究培训 (TLA-IPERT)
  • 批准号:
    9148176
  • 财政年份:
    2015
  • 资助金额:
    $ 18.05万
  • 项目类别:
Eureka Eurostars - TLA
尤里卡欧洲之星 - TLA
  • 批准号:
    600134
  • 财政年份:
    2010
  • 资助金额:
    $ 18.05万
  • 项目类别:
    EU-Funded
PROPERTIES AND FUNCTION OF TLA AND CD1 IN THE GUT
TLA 和 CD1 在肠道中的特性和功能
  • 批准号:
    2057361
  • 财政年份:
    1994
  • 资助金额:
    $ 18.05万
  • 项目类别:
PROPERTIES AND FUNCTION OF TLA AND CD1 IN THE GUT
TLA 和 CD1 在肠道中的特性和功能
  • 批准号:
    2057363
  • 财政年份:
    1994
  • 资助金额:
    $ 18.05万
  • 项目类别:
PROPERTIES AND FUNCTION OF TLA AND CD1 IN THE GUT
TLA 和 CD1 在肠道中的特性和功能
  • 批准号:
    2671349
  • 财政年份:
    1994
  • 资助金额:
    $ 18.05万
  • 项目类别:
PROPERTIES AND FUNCTION OF TLA AND CD1 IN THE GUT
TLA 和 CD1 在肠道中的特性和功能
  • 批准号:
    2517107
  • 财政年份:
    1994
  • 资助金额:
    $ 18.05万
  • 项目类别:
PROPERTIES AND FUNCTION OF TLA AND CD1 IN THE GUT
TLA 和 CD1 在肠道中的特性和功能
  • 批准号:
    2057359
  • 财政年份:
    1994
  • 资助金额:
    $ 18.05万
  • 项目类别:
PROPERTIES AND FUNCTION OF TLA AND CD1 IN THE GUT
TLA 和 CD1 在肠道中的特性和功能
  • 批准号:
    2057362
  • 财政年份:
    1994
  • 资助金额:
    $ 18.05万
  • 项目类别:
MURINE TLA GENES--ORGANIZATION, EXPRESSION, REGULATION
鼠 TLA 基因——组织、表达、调节
  • 批准号:
    3467995
  • 财政年份:
    1990
  • 资助金额:
    $ 18.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了